## Newton, C. A., Adeel, S., Sadeghi-Yarandi, S., Powell, W., Migdal, A., Smiley, D., . . . Toyoshima, M. (2013). Prevalence, quality of care, and complications in long term care residents with diabetes: a multicenter observational study. Journal of the American Medical Directors Association, 14(11), 842-846.##Feng, Y.-M., Zhao, D., Zhang, N., Yu, C.-G., Zhang, Q., Thijs, L., & Staessen, J. A. (2016). Insulin resistance in relation to lipids and inflammation in type-2 diabetic patients and non-diabetic people. PloS one, 11(4), e0153171. ##Shoelson, S. E., Herrero, L., & Naaz, A. (2007). Obesity, inflammation, and insulin resistance. Gastroenterology, 132(6), 2169-2180.##Teixeira-Lemos, E., Nunes, S., Teixeira, F., & Reis, F. (2011). Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties. Cardiovascular diabetology, 10(1), 1-15.##Fasshauer, M., & Blüher, M. (2015). Adipokines in health and disease. Trends in pharmacological sciences, 36(7), 461-470.##Murahovschi, V., Pivovarova, O., Ilkavets, I., Dmitrieva, R. M., Döcke, S., Keyhani-Nejad, F., . . . Hornemann, S. (2015). WISP1 is a novel adipokine linked to inflammation in obesity. Diabetes, 64(3), 856-866.##Esser, N., Legrand-Poels, S., Piette, J., Scheen, A. J., & Paquot, N. (2014). Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes research and clinical practice, 105(2), 141-150. ##Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996). IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α-and obesity-induced insulin resistance. Science, 271(5249), 665-670.##Plomgaard, P., Bouzakri, K., Krogh-Madsen, R., Mittendorfer, B., Zierath, J. R., & Pedersen, B. K. (2005). Tumor necrosis factor-α induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes, 54(10), 2939-2945.##Chakrabarti, P., & Kandror, K. V. (2015). The role of mTOR in lipid homeostasis and diabetes progression. Current Opinion in Endocrinology & Diabetes and Obesity, 22(5), 340-346.##Richter, E. A., & Hargreaves, M. (2013). Exercise, GLUT4, and skeletal muscle glucose uptake. Physiological reviews.##Pedersen, B. K., & Febbraio, M. A. (2012). Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nature Reviews Endocrinology, 8(8), 457-465.##Chang, J. S., Kim, T. H., & Kong, I. D. (2020). Exercise intervention lowers aberrant serum WISP-1 levels with insulin resistance in breast cancer survivors: A randomized controlled trial. Scientific reports, 10(1), 1-9.##Bahreini, A., & Fathi, R. (2017). Comparing the Effect of Eight Weeks of Interval and Continuous Aerobic Training on Serum Levels of WISP1 and TNF-α in Overweight/0bese Girls. Journal of Sport and Biomotor Sciences, 10(18), 1-12.##Association, A. D. (2020). 1. Improving care and promoting health in populations: Standards of Medical Care in Diabetes—2020. Diabetes care, 43(Supplement_1), S7-S13.##Saremi, A., Sh, S., & Kavyani, A. (2016). The Effect of Aerobic Training on Metabolic Parameters and 1SerumLevel of Sirtuin1 in Women with Type 2 Diabetes. AMUJ, 19(114), 88-97.##Jackson, A., & Pollock, M. (1978). Generalized equations for predicting body density of men. British Journal of Nutrition, 40(03), 497-504.##Siri, W. E. (1956). The gross composition of the body. Adv Biol Med Phys, 4, 239-280.##Fiorentino, T. V., De Vito, F., Suraci, E., Marasco, R., Hribal, M. L., Luzza, F., & Sesti, G. (2023). Obesity and overweight are linked to increased sodium‐glucose cotransporter 1 and glucose transporter 5 levels in duodenum. Obesity, 31(3), 724-731. ##Kermani, S., Abbassi Daloii, A., Abdi, A., & Saeidi, A. (2022). The effect of resistance training on hormones secreted from the adipose tissue (WISP-1 and WISP-2) in obese men. EBNESINA, 24(3), 15-24.##Davies, S. R., Davies, M. L., Sanders, A., Parr, C., Torkington, J., & Jiang, W. G. (2010). Differential expression of the CCN family member WISP-1, WISP-2 and WISP-3 in human colorectal cancer and the prognostic implications. International journal of oncology, 36(5), 1129-1136. ##Klimontov, V. V., Bulumbaeva, D. M., Fazullina, O. N., Lykov, A. P., Bgatova, N. P., Orlov, N. B., . . . Rudovich, N. (2020). Circulating Wnt1-inducible signaling pathway protein-1 (WISP-1/CCN4) is a novel biomarker of adiposity in subjects with type 2 diabetes. Journal of cell communication and signaling, 14(1), 101-109. ##Sahin Ersoy, G., Altun Ensari, T., Subas, S., Giray, B., Simsek, E. E., & Cevik, O. (2017). WISP1 is a novel adipokine linked to metabolic parameters in gestational diabetes mellitus. The journal of maternal-fetal & neonatal medicine, 30(8), 942-946. ##Hörbelt, T., Tacke, C., Markova, M., Herzfeld de Wiza, D., Van de Velde, F., Bekaert, M., . . . Seebeck, N. (2018). The novel adipokine WISP1 associates with insulin resistance and impairs insulin action in human myotubes and mouse hepatocytes. Diabetologia, 61(9), 2054-2065. ##Tacke, C., Aleksandrova, K., Rehfeldt, M., Murahovschi, V., Markova, M., Kemper, M., . . . Gerbracht, C. (2018). Assessment of circulating Wnt1 inducible signalling pathway protein 1 (WISP-1)/CCN4 as a novel biomarker of obesity. Journal of cell communication and signaling, 12(3), 539-548. ##Montgomery, M. K., & Turner, N. (2015). Mitochondrial dysfunction and insulin resistance: an update. Endocrine connections, 4(1), R1.##Barchetta, I., Cimini, F. A., Capoccia, D., De Gioannis, R., Porzia, A., Mainiero, F., . . . Leonetti, F. (2017). WISP1 is a marker of systemic and adipose tissue inflammation in dysmetabolic subjects with or without type 2 diabetes. Journal of the Endocrine Society, 1(6), 660-670. ##Tilg, H., & Moschen, A. R. (2008). Inflammatory mechanisms in the regulation of insulin resistance. Molecular medicine, 14(3), 222-231.##Rosenvinge, A., Krogh‐Madsen, R., Baslund, B., & Pedersen, B. (2007). Insulin resistance in patients with rheumatoid arthritis: effect of anti‐TNFα therapy. Scandinavian journal of rheumatology, 36(2), 91-96.##Hussey, S., McGee, S. L., Garnham, A., McConell, G., & Hargreaves, M. (2012). Exercise increases skeletal muscle GLUT4 gene expression in patients with type 2 diabetes. Diabetes, Obesity and Metabolism, 14(8), 768-771.##Gordon, J. W., Dolinsky, V. W., Mughal, W., Gordon, G. R., & McGavock, J. (2015). Targeting skeletal muscle mitochondria to prevent type 2 diabetes in youth. Biochemistry and cell biology, 93(5), 452-465. ##Wang, X., You, T., Murphy, K., Lyles, M. F., & Nicklas, B. J. (2015). Addition of exercise increases plasma adiponectin and release from adipose tissue. Medicine and science in sports and exercise, 47(11), 2450. ##DeFronzo, R. A. (2009). From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes, 58(4), 773-795. ##Kesherwani, V., Chavali, V., Hackfort, B. T., Tyagi, S. C., & Mishra, P. K. (2015). Exercise ameliorates high fat diet induced cardiac dysfunction by increasing interleukin 10. Frontiers in physiology, 6, 124##
)